887747-59-3

Upstream product

• 76-83-5 trityl chloride 
• 828930-37-6 p-tolyl 1-thio-β-D-xylofuranoside 
• 887747-58-2 p-tolyl 5-O-trityl-1-thio-β-D-xylofuranoside 
• 100-39-0 benzyl bromide 

Downstream Products

• 887747-60-6 p-tolyl 2,3-di-O-benzyl-1-thio-β-D-xylofuranoside 
• 887747-70-8 methyl 4-O-(2,3-di-O-benzyl-5-O-toluenesulfonyl-α-D-xylofuranosyl)-2,4,6-tri-O-benzyl-α-D-mannopyranoside 
• 887747-71-9 methyl 4-O-(2,3-di-O-benzyl-5-deoxy-5-methylthio-α-D-xylofuranosyl)-2,4,6-tri-O-benzyl-α-D-mannopyranoside 
• 887747-56-0 p-tolyl 2,3-di-O-benzyl-5-O-toluenesulfonyl-1-thio-β-D-xylofuranoside 
• 887747-81-1 methyl 5-deoxy-5-methylthio-2,3-di-O-benzyl-α-D-xylofuranoside 

Relevant academic research and scientific papers

IMMUNOMODULATORY SACCHARIDE COMPOUNDS

Compounds comprising a saccharide molecule and a 5-deoxy-5-methylthio-xylofuranose (MTX) moiety or a 5-deoxy-5-methylsulfoxy-xylofuranose (MSX) moiety, and use of such compounds in methods for modulating inflammation and immune responses.

The 5-deoxy-5-methylthio-xylofuranose residue in mycobacterial lipoarabinomannan. Absolute stereochemistry, linkage position, conformation, and immunomodulatory activity

Mycobacteria produce a cell-surface glycoconjugate, lipoarabinomannan (LAM), which has been shown to be a potent modulator of the immune response that arises from infection by these organisms. Recently, LAM from the human pathogens Mycobacterium tuberculo